Maternal serum free β‐hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies
- 1 June 1997
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 104 (6) , 741-743
- https://doi.org/10.1111/j.1471-0528.1997.tb11989.x
Abstract
Maternal serum free β‐hCG was measured at 10 to 14 weeks of gestation in 136 normal twin pregnancies and in 12 twin pregnancies where one or both fetuses had trisomy 21. The values were compared with a normal range from 4181 singleton pregnancies. In the normal twins the median free β‐hCG (65 ng/mL) was about twice as high as in singletons (34 ng/mL z=−12.1, P < 0.0001). In the trisomy 21 group the median free β‐hCG (95 ng/mL) was significantly higher than in normal twins (z= 2.1, P < 0.05). However, only one of the trisomic pregnancies had a level above the 95th centile. In twin pregnancies maternal serum free β‐hCG at 10 to 14 weeks of gestation is unlikely to be useful in the prediction of fetal trisomy 21.Keywords
This publication has 8 references indexed in Scilit:
- Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucencyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β-hCG and fetal nuchal translucency thicknessUltrasound in Obstetrics & Gynecology, 1995
- Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Maternal plasma levels of human chorionic gonadotrophin, oestradiol and progesterone in multifetal pregnancies before and after fetal reductionJournal of Endocrinology, 1994
- Down's syndrome screening in multiple pregnancies using alpha‐fetoprotein and free beta hCGPrenatal Diagnosis, 1994
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992